TheraJect
Fremont, California, United States
About TheraJect
TheraJect, Inc. is a preclinical stage biopharmaceutical company committed to the drug delivery including vaccines via a novel, needle-free transdermal technology. TheraJect is focused on enhancing the efficacy of existing vaccines, enabling new vaccines and expanding the global vaccine market.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $500.0K
- Last round: Grant (Aug 2012)
- Website: theraject.com
- Phone: 510-742-5832
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Canonical: https://fsome.com/organization/theraject-2511062 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.